Skip to main content
. 2018 Jun 1;34(6):527–535. doi: 10.1089/aid.2017.0245

Table 1.

Maternal and Infant Characteristics

Variable LRTI+N = 107 LRTI−N = 140 p
Maternal characteristics
 Race: n (%)
  Black 14 (14.7) 23 (17.7) .24
  Mestizo 6 (6.3) 19 (14.6)
  Other 3 (3.2) 5 (3.8)
  White 46 (48.4) 54 (41.5)
  Unknown 26 (27.4) 29 (22.3)
  Missing 12 10
 Substance use during pregnancy: n (%) exposed
  Alcohol 19 (17.8) 30 (21.7) .52
  Tobacco 21 (19.6) 37 (27.0) .23
  Marijuana 3 (2.8) 6 (4.5) .73
  Crack or cocaine 4 (3.8) 4 (3.0) 1.00
 Mean (STD) maternal age at enrollment 26.3 (5.0) 27.4 (5.8) .14
 Mean (STD) years of education 6.9 (3.2) 7.7 (3.2) .04
 Mean (STD) no. of prior pregnancies 2.3 (2.2) 2.3 (1.9) .98
 Mean (STD) parity 1.7 (1.5) 1.7 (1.7) .96
 Mean (STD) no. of people in household 4.4 (3.0) 4.0 (1.9) .14
 Mean (STD) CD4 count (cells/mm3) at hospital discharge 505.1 (239.5) 601.5 (287.1) .01
 Mean (STD) CD4% at hospital discharge 30.0 (9.4) 33.2 (11.1) .04
 Mean (STD) HIV viral load (log10 copies/mL) at hospital discharge 2.8 (0.8) 2.5 (0.8) .03
 HIV viral load <400 copies/mL at hospital discharge: n (%) 24 (34.3) 56 (58.3) .002
 Antiretrovirals during pregnancy: n (%)
  Zidovudine monotherapy 57 (53.3) 70 (50.0) .62
  Combination antiretrovirals 50 (46.7) 69 (49.3)  
  Unknown 0 (0.0) 1 (0.7)  
  Cotrimoxazole during pregnancy: n (%) Yes 14 (13.1) 15 (10.7) .92
Infant characteristics
  Female gender: n (%) 38 (35.5) 62 (44.3) .19
 Small for gestational age (<10th percentile): n (%)
  Yes 4 (3.7) 4 (2.9) .72
  No 103 (96.3) 136 (97.1)
 Large for gestational age (>90th percentile): n (%)
  Yes 14 (13.1) 13 (9.3) .41
 Mean (STD) gestational age at birth (weeks) 38.6 (1.1) 38.9 (1.2) .07
 Mean (STD) birth weight (g) 3145.5 (391.7) 3169.6 (369.6) .62
 Mean (STD) percent hematocrit at birth 41.4 (5.4) 42.6 (6.4) .12
 Mean (STD) hemoglobin at birth (g/dL) 14.2 (1.8) 14.6 (2.1) .15
 Mean (STD) red blood cell count at birth (106/μL) 3.7 (0.5) 3.8 (0.7) .11
 Mean (STD) white blood cell count at birth (103/μL) 11.5 (7.1) 11.5 (3.8) .97
 Mean (STD) days on zidovudine 42.8 (4.7) 43.4 (6.5) .25
 Used cotrimoxazole: n (%) yes 100 (93.5) 131 (93.6) .56
 Mean (STD) says of cotrimoxazole use 102.7 (39.4) 98.3 (43.7) .43

Bolded p values indicate significant and marginal differences. To adjust for one-to-n matching, p values for continuous measures were calculated by linear mixed-effects models; p values for categorical measures were calculated by conditional logistic regression.

LRTI, lower respiratory tract infection; HIV, human immunodeficiency virus.

STD, standard deviation.